SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Snodgrass who wrote (314)9/4/1997 11:31:00 PM
From: James Perry   of 834
 
I can't believe this. A research company exists to discover an important drug and get it to market. Once discovered, and after showing sufficiently good results without adverse reactions which outweigh its worth, it still takes years to get a new drug through the review process which allows it to ultimately be marketed. For exceptional drugs, there is a fast track process. This signals that the FDA considers this drug sufficiently important to grant it priority review, so that it can reach the public as promptly as possible. Wall Street reacts to profits, and because research companies make no money, stock prices are very low. This stock could easily double or triple by this time next year. And that is why this is good news.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News